[Event Report] The Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (March 19, 2020)
date : 5/27/2020
Tags: AMR
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
Working groups (WG) were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.
At this second meeting of WG1, WG1 members discussed the definition and categorization of pull incentives.
On the basis of WG discussions, participants agreed to join the second sub-committee on AMR and continue to work hard toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Thursday, March 19, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI)
■Discussion
WG1 Members (alphabetical order by last name):
Yusuke Ariyoshi (Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.)
Masashi Kawata (Senior Manager, Public Affairs & Policy, Corporate Affairs, Health & Value, Pfizer Japan Inc.)
Tatsuro Kuzuki (Scientific Liaison, DNDi Japan)
Shoji Miyagawa (Director, Division of Infectious Disease Research, The Japan Agency for Medical Research and Development (AMED))
Akio Ozaki (Director, Public and Industry Policy, Health Policy, MSD K. K.)
Yosuke Sugiyama (Manager, Trade Associations & Regional Support, Global Public Affairs, Corporate Communications & Public Affairs, Takeda Pharmaceutical Company Limited)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Moderator:
Joji Sugawara (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Secretariat (alphabetical order by last name):
Matt McEnany (AMR Alliance Japan Secretariat/Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Chiaki Toma (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
Mio Wakasa (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
Featured Posts
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: October 1, 2026)
-
2026-09-01
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 6: Japan’s Health Policy through the Lens of Global Security” (October 13, 2026)
-
2026-09-17
[Registration Open] (Webinar) The 145th HGPI Seminar “Toward Better AMR Measures at Elderly Care Facilities—Considering Infectious Disease Control in a Super-Aged Society From a Policy Perspective” (October 27, 2026)



